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Abstract
Background: Differences in life expectancy (LE) between social groups in a specific country are a fundamental
measure of health inequalities within that country. Constant monitoring of these differences provides important
information on the population’s general health. The purpose of the present study is to explore and quantify the
socio-economic differences in LE in Germany, focussing on a topic rarely assessed in other studies, the
dependency of these LE differences on the presence of myocardial infarction or diabetes mellitus.
Methods: The dataset consists of 13,427 participants (6,725 men, 6,702 women) aged 25-74 years, recruited in the
region of Augsburg in Germany through three independent cross-sectional representative surveys conducted in
1984/85, 1989/90, 1994/95, with a mortality follow up in 1998 and 2002. We use a parametric model for the
survival function based on the Weibull distribution, in which the hazard function is described in terms of two
parameters. We estimate these parameters with a maximum likelihood method that takes into account censoring
and data truncation.
Results: The difference in LE between the lowest and the highest socio-economic group is estimated to be 3.79
years for men and 4.10 years for women. Diabetes mellitus reduces LE of men from the upper three income
quartiles by 4.88 years, and LE of men belonging to the lowest income quartile by 7.97 years. For women, the
corresponding figures are 5.79 and 5.72 years. Myocardial infarction reduces LE of men and women from the
upper three income quartiles by 3.65 and 3.75 years, respectively, and LE of men and women belonging to the
lowest income quartile by 5.11 and 10.95 years, respectively.
Conclusions: This study shows that in Germany the differences in LE by socio-economic status are comparable to
those found in other European countries, and that these differences seem to increase when diabetes mellitus or
myocardial infarction is present. The statistical method used allows estimates of LE with relatively small datasets.
Background
Life expectancy (LE) is an estimate of the average num-
ber of years that a person can expect to live. It can be
defined both at birth and at any later age. It reflects the
mortality rates of a population as a function of age for
the year for which it is calculated. As such, it is only
dependent on the observed average age-specific death
rates and it should not be viewed as a reflection of
future mortality rates [1].
From a public health perspective, LE at birth repre-
sents a fundamental measure of a population’s state of
general health. Differences in LE between different social
groups are a measure of health inequalities within a
country. Constant observation of LE over time allows
one to assess whether a health gap between different
socio-economic groups exists, whether the gap widens
or narrows, and whether public health initiatives are
effective.
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according to socio-economic status in European [2,3]
and non-European countries [4-6]. The magnitude of
these differences varies among the different countries.
However, socio-economic differences in LE of persons
w i t has p e c i f i cd i s e a s eh a v en o tb e e ne x p l o r e di n
any detail. Research has mostly focused on the socio-
economic differences in mortality in patients with
diseases, such as diabetes [7,8], rather than on the
socio-economic differences in life expectancy in these
populations.
While the differences in LE among different social
groups are a measure of health inequalities within a
country, the LE gap within disease groups represents a
possible measure of health inequalities within a health
care system. If socio-economic differences in LE increase
when a disease such as diabetes or myocardial infarction
is present, this could indicate that the health care sys-
tem is not capable of reducing health inequalities
among patients. While the length of the LE per se is
important for estimates within a country, relative reduc-
tion of the LE between socioeconomic groups is impor-
tant when examining disease groups.
The estimation of LE within disease groups represents
a very concrete measure that health authorities can use
to monitor relevant health care systems. Reports of
socio-economic differences in terms of LE instead of
mortality are more suitable for illustrative purposes [9],
since its repercussions for the population are easier to
grasp and to report. While LE is easier to understand
and communicate than mortality, its estimation presents
two main difficulties related to obtaining the necessary
amount of data [10], and to methodical issues [11]. This
might explain why the research has mostly focused on
differences in mortality within disease groups and not
on LE.
Estimating LE by socio-economic status would ideally
require a comprehensive census of a population linking
socio-economic data with the deaths and births
recorded in the year of the census. In countries not
allowing this kind of data-linkage system among datasets
in public registers, one can only calculate LE by socio-
economic status within disease groups by using other
data. Scientific datasets are required which contain data
on the diseases of interest and data on socio-economic
status and mortality.
These data are very difficult to obtain since they
require a very long mortality follow up and also have
methodological problems related to the relatively small
number of people in the dataset and possible measure-
ment bias due to left-censored data. The latter arises
because study participants have already reached a cer-
tain age, while mortality data for persons who deceased
at younger ages is left-truncated.
In this paper we measure LE differences among per-
sons with diabetes and myocardial infarction with data
collected in Germany. This allows us to make an impor-
tant contribution to the state of the research on the LE
in general and in Germany in particular, where the lit-
e r a t u r eo nt h et o p i ci ss c a r c ea n dac h r o n o l o g i c a lt r e n d
is lacking. While, the health gap measured by calculating
the differences in LE has recently gained some attention
in Germany [e.g. [12-14]], the socio-economic differ-
ences in LE of patients with myocardial infarction or
diabetes mellitus have not been measured yet.
Furthermore, monitoring the impact of socio-eco-
nomic differences on health is important in Germany,
since the social inequality regarding the traditional
socio-economic indicators, like income, educational level
and professional status, is increasing in this country.
Economic indicators show that income inequality has
increased in recent years [15]. From a public health per-
spective, it is important to assess whether widening
socio-economic differences are reflected in widening
socio-economic gaps in life expectancy, such as seen in
the UK and the USA [16,4], and in widening socio-eco-
nomic gaps in life expectancy among persons with the
same disease.
In Germany, there are very few datasets covering a
long follow up period and including all the data neces-
sary for a LE analysis by socioeconomic status and dis-
ease. Probably the best is provided by the dataset of the
WHO MONICA study (multinational MONItoring
trends and determinants in CArdiovascular disease), and
KORA study (Cooperative Health Research in the
Region Augsburg; following after MONICA in the same
r e g i o n ,i . e .A u g s b u r g ) .W eu s et h eM O N I C A / K O R A
dataset to explore and quantify first the socio-economic
differences in LE and then the impact of diabetes and
myocardial infarction on LE of people belonging to dif-
ferent socio-economic groups. By detailed description of
the statistical method used for calculating LE, we
attempt to improve the accessibility of this kind of ana-
lysis for other studies.
Methods
Description of the data
The MONICA project started in the early 1980s under
the initiative of the World Health Organization. The
aim of the project was to investigate the causes and
trends of cardiovascular disease. The Augsburg region
of Bavaria in Germany, whose population structure
reflects that of Germany as a whole [17], served as study
region of the MONICA project. In 1996, KORA was
established in the Augsburg region with the goal of con-
tinuing the MONICA project and of exploring other
health issues such as diabetes, allergies, health econom-
ics, genetic, and environmental questions.
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three independent cross-sectional population-based
representative surveys carried out in 1984/85 (response
rate: men 80.0%, women 78.7%), 1989/90 (response rate:
men 76.4%, women 77.2%), and 1994/95 (response rate:
men 74.0%, women 76.8%) in the region of Augsburg
within the international WHO MONICA project. The
age of the participants was 25-64 years for the first sur-
vey, and 25-74 years for the last two. 13,427 persons
(6,725 men, 6,702 women) took part in the surveys. In
1998 and in 2002, as part of the KORA project, the vital
status of the participants was assessed through the
population registries [18]. By 31st December 2002, 1,554
persons (1,032 men, 522 women) had died.
Per capita income
In our dataset the variable ‘net household income’ was
measured in 8 categories (all figures in DM): < 1000,
1000 to < 1500, 1500 to < 2500, 2500 to < 3500, 3500
to < 4500, 4500 to < 5500, 5500 to < 6000, > 6000. In
order to calculate the income level, we first calculated
the ‘mid-points’ of each income class. For the lowest (<
1000) and highest (> 6000) income class we calculated
two-thirds and four-thirds of the corresponding limits
[19], respectively. The resulting values were then divided
by the number of household members, yielding the new
variable ‘per capita income’, which was roughly divided
into terciles (low, medium or high per capita income).
Education
The dataset also includes a variable distinguishing three
educational levels:
Low ‘Hauptschule/Volksschule’ (lower secondary
school certificate)
Medium ‘Realschule/Mittlere Reife’ (upper secondary
school certificate)
High ‘Abitur/Fachabitur/Fachhochschule’ (qualification
for university entrance/completion of undergraduate
studies)
Socio-economic status
An important part of the literature [20] holds that the
most common indicators of social status - income, edu-
cation, and working position - cannot be used inter-
changeably as they represent different dimensions and
different causal processes on the development of health
outcomes. Following this approach, we separately inves-
tigated the independent contribution of income and
education to the estimation of LE in Germany. As, how-
e v e r ,w ea l s ow a n t e dt ob u i l dt w ov e r yd i s t i n c ts o c i o -
economic groups, such as a group ranking low (resp.
high) in both education and income, we constructed an
additional variable - ‘socio-economic status’ - defined by
combining the indicators income and education level as
follows:
Low low income level - plus - low educational level
Medium medium income level - plus - medium edu-
cational level
High high income level - plus - high educational level
Within each of these three socio-economic groups, the
estimated LE was calculated in the total sample, sepa-
rately for men and women.
The analysis of the impact of diabetes and myocardial
infarction on the LE was made by comparing only the
following two income groups: ‘low’ (< lowest quartile)
on one hand and ‘medium or high’ (other quartiles) on
the other hand, because the sub-sample of participants
with diabetes mellitus and myocardial infarction (n =
542 and n = 262, respectively) was too small for a finer
grading of the income groups. The small number of
deceased persons in the highest education groups also
prevented us from performing an additional analysis
with the indicator education among people with diabetes
or myocardial infarction. In the highest educational
level, there were, in fact, only 11 deceased men and 3
deceased women among those with diabetes, and 9
deceased men and no deceased woman among those
with a myocardial infarction.
An increasingly important aspect of social epidemiol-
ogy is the impact of inhomogeneity of the socio-eco-
nomic indicators in a person on the development of
health outcomes [21]. We analysed the impact of this
status inconsistency on the LE of two groups character-
ized by high income (third tercile) and low educational
level (lower secondary school), and by low income (first
tercile) and high educational level (qualification for uni-
versity entrance/completion of undergraduate studies),
respectively. However, due to the limited number of
deceased cases (n = 3) among those with diabetes or
myocardial infarction in the latter group, we were not
able to estimate the effects of status inconsistency on
the reduction of LE within this group. This is why we
conducted this further analysis only among the group
characterized by high income and low educational level.
Diabetes mellitus and myocardial infarction
The data relating to diabetes mellitus and myocardial
infarction were collected by asking the participants
whether they had been diagnosed with diabetes (type 1
or type 2) by a physician, or whether they took medica-
tion against it (if yes, they were asked to show the medi-
cation taken), or whether they have been treated in
hospital because of a myocardial infarction. A positive
answer to these questions was assumed to indicate that
they had diabetes or myocardial infarction. Focusing on
these two diseases gave us the possibility of analysing
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tively, on the LE. As, however, diabetes is a risk factor
for cardiovascular disease, this created some overlap in
our analysis. In particular, 43 persons with diabetes also
had a myocardial infarction.
Statistical analysis
In this analysis, due to the limited sample size, a para-
metric model, the Weibull distribution, is used for the
underlying distribution of survival times. In this model
the hazard function increases with age and is described
in terms of two parameters.
We also used a non-parametric method to check
whether the basic functional shape assumed for the dis-
tribution function was reasonable or not. In particular, a
non-parametric estimate of the hazard function was cal-
culated for the present data set and the result was com-
pared with the hazard function that is assumed in the
parametric Weibull model. The test showed that the
non-parametric estimate of the hazard function
increased with time and is well fit by the Weibull model
with a hazard increasing with time. This provides good
evidence that the parametric model used in the remain-
der of our analysis is adequate.
For the Weibull distribution, the survival function can
be written as
St t ( ) exp( )  

This function gives the probability of a person to
reach an age larger than t. SAS® provides a built-in sta-
tistical procedure (LIFEREG) for a maximum likelihood
estimate of the parameters a and g for right-censored
data, which is the relevant case for this analysis since
the people of the data set who are still alive effectively
constitute right censored data points. More specifically,
SAS® actually outputs two related parameters, an “inter-
cept” μ and a “scale” s, which are related to a and g by
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and the LE can be computed as
texpected  ( )exp( ) 1 
Here Γ denotes the gamma-function.
In addition, LIFEREG supports the estimation of the
influence of individual variables on the life expectancy,
where their influence is combined in a linear model.
This assumes that the influence of the individual vari-
ables is mutually independent. For example, if we con-
sider socio-economic status and diabetes as variables,
this procedure can estimate the separate and combined
impact of these two variables on life expectancy, but it
cannot be used to study if the impact of diabetes varies
between different socio-economic groups, as by con-
struction such correlations are not considered in the lin-
ear model. A possible solution lies in forming separate
groups for each combination of the considered variables,
and in estimating LE individually for these samples. We
apply this method in estimating LE for people with dia-
betes (unadjusted for myocardial infarction) and in esti-
mating LE for people with myocardial infarction
(unadjusted for diabetes). We also carry out a separate
analysis where we estimate the LE of people with dia-
betes by adjusting for myocardial infarction, and vice
versa. This is done by considering diabetes and myocar-
dial infarction as additional variables of influence in
maximum likelihood estimates with LIFEREG. We
always consider ‘sex’ as one variable of influence in
order to avoid that the strong difference between men
and women distorts our estimates.
A limitation of our dataset is that the participants
entered the study after already having reached a certain
age t0. Data for people who died before t0 does not exist
in the study, which constitutes a case of left data trunca-
tion. If this is simply ignored, the absolute values of the
estimated life expectancies will be biased high, because
the drop of the survival function from birth to age t0
has been ignored. A better method is to properly
include the information about the age of the people
when they entered the MONICA/KORA study. Let this
age be t0. Then the probability to survive at least until
age t >t0 is given by S*(t, t0)=S(t)/S(t0), and the prob-
ability density to die at age t is f*(t, t0)=- d S*/dt.W h e n
the vital status is checked a few years later, some people
will have died at an age t1 in between. The others have
ap r e s e n ta g et1, and constitute right-censored data,
since for them the event of death lies at some unknown
time t >t1.
The proper log-likelihood function to observe the data
set given the survival function model is hence
Lf t S t S t      ln ( ) ln ( ) ln ( ) 11 0
all censored uncensored
Maximizing this likelihood yields the correct life
expectancies that are not biased due to the finite age
of people entering the MONICA/KORA study. The
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except that the last sum in t h ea b o v ee q u a t i o ni sm i s s -
ing. We have implemented in SAS® a program that max-
imizes the correct likelihood, finding that it gives values
for the LE about 1 year lower than what is obtained
with LIFEREG. The size of this bias is hence quite mod-
erate, which can be easily understood due to the low
mortality of people at age 0-25, which is the age range
entirely missing in the MONICA/KORA dataset. As we
a r eo n l yi n t e r e s t e di nrelative differences in LE between
the different groups studied, we for simplicity ignore the
bias for the statistical analysis. Note however that this
means that absolute life expectancies are actually about
1 year lower than all the values quoted in the following.
The statistical analysis was conducted with the help of
SAS® Version 9.1 (SAS Institute Inc., Cary, NC, USA)
Results
The basic distribution of the variables is shown in
table 1. It can be pointed out, for example, that low
educational level is very common (about 66%), that
information on income is missing for 1,799 out of
13,427 (13%), and that 4,679 participants (35%) are
included in our definition of socio-economic status (i.e.
combining educational level and income in three very
distinct groups). Overall, 1,554 participants (12%) have
died during the follow up period. Concerning partici-
p a n t sw i t hd i a b e t e sm e l l i t u s ,t h i sp e r c e n t a g ei sm u c h
higher (40%; i.e. 219 from 542 participants) and it is still
higher for participants with myocardial infarction (46%,
i.e. 121 from 262 participants).
The results of the statistical analysis of LE show that
t h ed i f f e r e n c ei nL Eb e t w e e nt h ep a r t i c i p a n t si nt h e
study who have a low socio-economic status (i.e. low
income - plus - low educational level) and those who
have a high socio-economic status (i.e. high income -
plus - high educational level) is 3.79 (82.77 vs. 78.98)
years for men and 4.10 (89.63 vs. 85.53) years for
women (table 2). A very similar, but more detailed asso-
ciation is seen in the survival curves (figures 1).
The impact of diabetes on LE differs by income
(table 3). On one hand, men with diabetes and higher
income (upper three quartiles) have a shorter LE of 4.88
years compared to men belonging to the same income
g r o u pb u tw i t h o u td i a b e t e s( 7 6 . 2 4vs. 81.12); on the
other hand, men with diabetes and a lower income (low-
est quartile) have a shorter LE of 7.97 years as compared
to men from the same income group without diabetes
(72.76 vs. 80.73). Thus, it can be concluded that diabetes
shortens the LE of poorer men considerably more than
the LE of richer men, in fact, the difference amounts to
about 3 more years (7.97 vs. 4.88 years). Concerning
women, the reduction of LE in the diabetes group (as
compared to the non diabetes group) is about 5.72 years
for lower income (87.08 vs. 81.36) and 5.79 years for the
higher income (87.77 vs. 81.98).
Similar results are obtained in calculating the impact
of myocardial infarction on LE (table 4). The difference
in LE in the higher income group amounts to about
Table 1 Basic distribution of the variables
Variable Total sample Deceased persons
Mean Variance Mean Variance
Age
- men 48.43 13.63 67.92 10.18
- women 47.87 13.48 69.93 9.51
N% N %
Sex
- men 6725 50.09 1032 66.41
- women 6702 49.91 522 33.59
- total 13427
Per capita income (quartiles)
a
- low 2841 24.43 339 26.84
- medium/high 8787 75.57 924 73.16
- missings 1799 291
Socioeconomic status
b
- low 2946 62.96 360 76.11
- medium 762 16.29 54 11.42
- high 971 20.75 59 12.47
Health status
- diabetes mellitus
c 542 4.04 219 14.09
- missings 3 0
- myocardial infarction
d 262 1.95 121 7.79
- missings 2 0
a) Low: < lowest quartile (i.e. < 667DM)
Medium/High: ≥ lowest quartile (i.e. ≥ 667DM)
b) Low: combination of low educational level and low per capita income
Medium: combination of medium educational level and medium per capita
income
High: combination of high educational level and high per capita income
c) Self-report of physician diagnosis or utilization of drugs against diabetes
mellitus
d) Self-report of hospitalization because of myocardial infarction
Table 2 Mean life expectancy at birth by socioeconomic
status
Socioeconomic
status
a
Life expectancy
(years)
95% Confidence
limits
Men Low 78.98 76.07 - 81.99
Medium 80.44 77.22- 83.80
High 82.77 80.70 - 84.88
Women Low 85.53 82.38 - 88.80
Medium 87.11 83.62 - 90.75
High 89.63 87.39 - 91.92
a) Low: combination of low educational level and low per capita income
Medium: combination of medium educational level and medium per capita
income
High: combination of high educational level and high per capita income
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myocardial infarction vs. 77.32 for those who had a
myocardial infarction), and3 . 7 5y e a r sf o rt h ew o m e n
(87.29 years for those without a myocardial infarction
vs. 83.54 for those with a myocardial infarction). Among
the lower income group the difference is 5.11 years for
the men (80.26 years for those without a myocardial
infarction vs. 75.15 for those who had a myocardial
infarction) and 10.95 years for the women (86.79 years
for those without a myocardial infarction vs. 75.84 for
those who had a myocardial infarction). Thus, myocar-
dial infarction shortens the LE of poorer men more
than the LE of richer men (5.11 vs. 3.65 years), and a
very similar but more pronounced association can also
be seen for women (10.95 vs. 3.75 years). This latter
result, however, carries a large statistical uncertainty and
may not be significant due to the relatively small num-
ber of women who suffered from a myocardial infarction
(53 women vs. 209 men) and died (17 women vs. 104
men). Similarly in the case of diabetes, where the num-
ber of deceased participants among the women is almost
half compared with men (79 vs. 140).
The differences in LE are illustrated in figures 2 and 3.
Figure 2 shows the differences in LE between the higher
and the lower income group. It can be seen, for exam-
ple, that this difference is greater for men and women
with myocardial infarction than for men and women
without myocardial infarction, and greater for men with
diabetes than for men without diabetes. Figure 3 shows
the differences in LE between people without resp. with
myocardial infarction or diabetes. It can be seen, for
example, that this difference is greater for the lower
than for the higher income group, concerning men and
women with (resp. without) myocardial infarction, and
also concerning men with (resp. without) diabetes.
The socio-economic gap in the estimated LE remains
stable both for men and women with diabetes or myo-
cardial infarction if the impact of the other disease (i.e.
myocardial infarction for people with diabetes, and vice
versa) is controlled for in the logistic regression model
(tables 5 and 6).
Further analyses (not presented here in tables or fig-
ures) have been conducted looking at the educational
and income levels separately. The results show that
while the LE of men with a high education is approxi-
mately one year shorter than the LE of those who have
high education and high income (81.96 vs. 82.77), the
LE of those belonging to the low education group is
approximately one year longer than the LE of those
men who have low income and low educational level
(79.71 vs. 78.98). For the women this reduction of
approximately one year only applies to those belonging
to the high educational level (88.37 vs. 89.63). For the
low education group there is no such difference (85.57
vs. 85.53).
Looking just at the income, the LE of those men and
women belonging to the lower income group remains
almost unchanged if compared to the LE of those who
have low income and low education (79.06 vs. 78.98 and
85.95 vs. 85.53, respectively). The LE of men and
women belonging to the higher income group is instead
reduced by approximately one year if compared to the
Figure 1 Survival function according to socioeconomic status.
Low: combination of low educational level and low per capita
income. Medium: combination of medium educational level and
medium per capita income. High: combination of high educational
level and high per capita income.
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Page 6 of 11Table 3 Mean life expectancy at birth by income and diabetes mellitus
Income Diabetes mellitus Life expectancy (years) 95% Confidence limits
Men lower (lowest quartile) Yes 72.76 68.29 - 77.52
higher (other quartiles) Yes 76.24 73.47 - 79.13
lower (lowest quartile) No 80.73 78.36 - 83.17
higher (other quartiles) No 81.12 79.80 - 82.46
Women lower (lowest quartile) Yes 81.36 77.01 - 85.96
higher (other quartiles) Yes 81.98 79.37 - 84.68
lower (lowest quartile) No 87.08 84.52 - 89.74
higher (other quartiles) No 87.77 86.32 - 89.25
Table 4 Mean life expectancy at birth by income and myocardial infarction
Income Myocardial infarction Life expectancy (years) 95% Confidence limits
Men lower (lowest quartile) Yes 75.15 68.26 - 82.73
higher (other quartiles) Yes 77.32 72.76 - 82.18
lower (lowest quartile) No 80.26 78.01 - 82.58
higher (other quartiles) No 80.97 79.71 - 82.24
Women lower (lowest quartile) Yes 75.84 69.45 - 82.81
higher (other quartiles) Yes 83.54 78.75 - 88.63
lower (lowest quartile) No 86.79 84.37 - 89.27
higher (other quartiles) No 87.29 85.93 - 88.67
Figure 2 LE of people with higher income - minus - LE of people with lower income. LE: life expectancy; DM: diabetes mellitus; MI:
myocardial infarction. lower income: lowest quartile; higher income: upper three quartiles.
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Page 7 of 11Figure 3 LE of people without MI/DM - minus - LE of people with MI/DM. LE: life expectancy; DM: diabetes mellitus; MI: myocardial
infarction. lower income: lowest quartile; higher income: upper three quartiles.
Table 5 Mean life expectancy at birth by income and diabetes mellitus adjusted for myocardial infarction
Income Diabetes mellitus Life expectancy (years) 95% Confidence limits
Men lower (lowest quartile) Yes 73.48 68.93 - 78.33
higher (other quartiles) Yes 76.53 73.72 - 79.44
lower (lowest quartile) No 81.13 78.74 - 83.60
higher (other quartiles) No 81.40 80.06 - 82.75
Women lower (lowest quartile) Yes 81.71 77.26 - 86.42
higher (other quartiles) Yes 82.09 79.46 - 84.81
lower (lowest quartile) No 87.23 84.63 - 89.89
higher (other quartiles) No 87.89 86.42 - 89.38
Table 6 Mean life expectancy at birth by income and myocardial infarction adjusted for diabetes mellitus
Income Myocardial infarction Life expectancy (years) 95% Confidence limits
Men lower (lowest quartile) Yes 76.19 69.19 - 83.90
higher (other quartiles) Yes 77.83 73.26 - 82.70
lower (lowest quartile) No 80.84 78.57 - 83.18
higher (other quartiles) No 81.51 80.24 - 82.81
Women lower (lowest quartile) Yes 77.90 70.85 - 85.64
higher (other quartiles) Yes 84.36 79.41 - 89.61
lower (lowest quartile) No 87.58 85.05 - 90.18
higher (other quartiles) No 87.97 86.53 - 89.41
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high education (81.83 vs. 82.77 and 88.57 vs. 89.63,
respectively).
Our results also show that the effects of status incon-
sistency on the LE are noticeable. Those men and
women, in fact, who have an income corresponding to
the lowest tercile and an education corresponding to a
qualification for university entrance/completion of
undergraduate studies have a LE shorter than those men
and women characterized by low income plus low edu-
cation. The corresponding figures are a reduction of
about one and half year for the men (77.16 vs. 78.98)
and 3 years for the women (82.97 vs. 85.53). On the
contrary, those men and women characterized by an
income corresponding to the highest tercile and an edu-
cation corresponding to a lower secondary school have
a longer LE than those having low income plus low edu-
cation, and a shorter LE than those having high educa-
tion and high income. The corresponding figures are
80.78 vs. 78.98 and 80.78 vs. 82.77 for the men, and
86.86 vs. 85.53 and 86.86 vs. 89.63 for the women.
The reduction of the LE among those who have dia-
betes or myocardial infarction and high income plus low
education is not very pronounced if compared to the
group of men earning more than the lowest quartile.
The corresponding figures concerning the groups with
diabetes are a reduction of 5 years for the men (75.67
vs. 80.53), and 4 years for the women (82.73 vs. 86.91).
Almost unchanged are also the results for the men hav-
ing myocardial infarction if compared to the group of
m e nw i t hh i g hi n c o m e( 7 7 . 1 2vs. 80.31 and 77.32 vs.
80.97, respectively). In the group of women, the reduc-
tion is about 2 years (84.47 vs. 86.52).
Discussion
The results of our study agree with the findings of a EU
report in 2006 [3], including data from 21 different Eur-
opean countries, in which differences in LE at birth
between the lowest and highest socio-economic groups
are estimated to be between 4-6 years among men and
2-4 years among women. They also agree with German
studies conducted with other datasets and confirm that
in Germany there is a socio-economic gap in life expec-
tancy. For example, a recent German study [14] con-
ducted with administrative records from the German
Public Health Pension System found that LE rises
almost linearly with lifetime earnings - a proxy for
socio-economic status. An analysis conducted with data
of the LE-Survey [22] showed that while 45-year-old
men, who work as “Beamte” (public officers), have a
remaining LE of about 32 years, manual workers have a
remaining LE of about 26 years. Among women, the LE
gap between 45-year-old “Beamte” and simple employ-
ees is estimated to be about 5 years. The data of the
socio-economic panel (SOEP) have provided the basis
for different analyses which all showed the existence of
a socio-economic gap in LE. Lauterbach et al. [23] cal-
culated that the probability to reach retirement age for
the men belonging to a lower income group (< 1,500
E u r o )c o m p a r e dt ot h o s eb e longing to a higher income
group (> 4,500 Euro) is 79,1% and 90,0%, respectively.
Lampert et al. [13] estimated that the difference in
“healthy” LE among men and women earning less than
60% of the median of the income in Germany and those
earning more than 150% of the median is about 14
healthy years for the men and 10 for the women.
Possible reasons that would explain the differences in
LE by socio-economic status have been amply discussed
in the literature [24]. They include explanations related
to different life styles among lower and higher socio-
economic groups. This has also been investigated by
another study using the German MONICA/KORA data
[25], which showed that men and women with a higher
educational level have a lower consumption of tobacco
and alcohol, are more likely to engage in leisure-time
physical activity, have a lower Body Mass Index, and
have less job strain.
Our results also show that if German men and women
with lower income have diabetes or myocardial infarc-
tion then their LE is reduced more by the disease than
the LE of richer men. Adjustment for diabetes and myo-
cardial infarction for people with myocardial infarction
and diabetes, respectively, yields only very limited
changes of the LE estimates. This means that the influ-
ence of the interaction of these diseases on the reduc-
tion of LE is negligible, and that the reduction in LE lies
mostly in the social differences in our regression model.
This indirectly confirms the results of a German study,
also conducted in the region of Augsburg, which
showed that the number of deceased persons with a first
time myocardial infarction was about 60% higher among
those belonging to a lower socio-economic group com-
pared to those belonging to a higher socio-economic
group [26]. Another German study demonstrated that
p e r s o n sw i t hd i a b e t e sm e l l i t u sb e l o n g i n gt oal o w e r
socio-economic group are more susceptible to diabetes-
specific complications, such as micro and macrovascular
c o m p l i c a t i o n s ,c o m p a r e dt ot h o s ew h ob e l o n gt oa
higher socio-economic group [27]. Clearly, a higher fre-
quency of diabetes-specific complications could contri-
bute to a shorter life expectancy.
Income and education seem to have similar effects on
the LE of both men and women. Computation of LE
based on separate analyses of income and education
yielded similar estimations (79.06 vs. 79.71 and 81.83 vs.
81.96 for the men in the lower and higher groups,
respectively, and 85.57 vs. 85.95 and 88.57 vs. 88.37 for
the women). These figures also show that the social
Perna et al. BMC Public Health 2010, 10:135
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the group with the best LE in our analysis.
The group of those men and women who have an
income corresponding to the lowest tercile and an edu-
cation corresponding to a qualification for university
entrance/completion of undergraduate studies has the
worst LE in our analysis. This group would also prob-
ably show the most significant reduction in LE when
affected by a disease [21]. In our dataset, the limited
number of cases did not make an estimation of LE
within the group of patients with diabetes or myocardial
infarction possible. This remains an important topic for
future research.
The value of the estimated mean life expectancy is
higher than the mean LE reported by the 2002/2004 life
table for Germany (men: 75.89; women: 81.55) and by
the Bavarian life table, whose values (men: 76.47;
women: 81.92) are the second highest among the Ger-
man states. Our estimation remains slightly higher, even
after correction of the left data truncation. However,
this hardly affects the study results, whose major pur-
pose is to show a gradient among different socio-eco-
nomic groups and not to calculate a precise estimate of
the LE of a newborn baby, if the current death rates
continue to apply throughout his or her life. A possible
reason for the difference resides in the small number of
old and deceased people in the available dataset. This is
particularly true in the case of women where the num-
ber of deceased participants (522) is almost half com-
pared with men (1032), implying that the survival data
of women is more heavily censored. Another reason
could also lie in an over-representation of health con-
scious persons in the dataset, as health conscious per-
sons are, presumably, more inclined to participate in a
study dealing with health issues, and having a healthier
lifestyle, they might live longer.
Most 95% confidence limits of the LE value overlap
with other groups. This is largely due to the relatively
small number of deceased people in the available data.
However, it should be noted that the degree of overlap
between the confidence intervals does not directly quan-
tify the statistical significance regarding the existence of
a difference between the life expectancies of the different
groups.
The use of a parametric method was appropriate for
the present analysis. Parametric methods are particularly
useful to investigate small changes induced in the distri-
bution function by certain data variables (e.g. sex, socio-
economic status in the case of life expectancy). Also,
they are more powerful than non-parametric methods
for sparse data, provided the assumed shape for the
underlying distribution function is a reasonable descrip-
tion of the data. The principal advantage of non-para-
metric methods is that they are free of any assumptions
regarding the underlying distribution function, which
protects against potential biases in the results if a para-
metric method is used with a distribution function that
is actually a poor match for the data. However, the lar-
ger freedom regarding possible distribution functions
explored by non-parametric methods means that data-
sets need to be very large to obtain accurate results with
this method. Also, it is often difficult to extrapolate the
estimated non-parametric distribution function into
regimes that are not well sampled by the data. This is
for example the case in building a life table with the
MONICA/KORA data; the tail of the age distribution is
in fact not well determined by non-parametric methods
due to the small number of deceased people in the
available data.
The small sample was clearly a limitation of this ana-
lysis and biased the estimates of LE. The inclusion in
the survey of only people aged between 25-74 years and
the absence of people living in institutions also limited a
precise quantification of life expectancy. The survey is
also limited by the regional data collection and possible
recruitment bias.
While these limitations did not allow a robust estima-
tion of absolute life expectancy, the results of the study
confirmed, as have other German and international stu-
dies, the existence of a socio-economic gap in life expec-
tancy. The study also provides important new
information by addressing a public health topic rarely
discussed to date, i.e. the socio-economic differences in
the relative reduction of LE of people who have diabetes
mellitus or myocardial infarction.
Conclusions
This study confirms the existence of a socio-economic
gap in LE in Germany and shows that the differences in
LE by socio-economic status are comparable to those
found in other European countries. It also measures, for
the first time, the differences in the reduction of LE of
persons who have diabetes mellitus or myocardial
infarction for different income groups. In most cases the
LE differences seem to increase when one of these dis-
eases is present, indicating that the German health care
system is not successful in reducing the LE differences
among these patients. It would be reasonable to claim
that the health care system should be able to reduce
health inequalities among the patients, as patients with
a higher need for health care (e.g. those in a lower
income group) should receive more health care. The
opposite seems to be the case, though, and it could be
concluded that in the health care system more resources
should be directed towards lower socio-economic status
patients.
Concerning the statistical methods proposed here, the
description of this method could help in making the
Perna et al. BMC Public Health 2010, 10:135
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Page 10 of 11estimation of the socio-economic gap in countries with-
out a data-linkage system among the entries in public
registers, such as Germany, more accessible.
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